GLP-1 drugs like Ozempic have become massively popular for their slimming side effects, but understanding of their effects is lagging.
Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...
Novo Nordisk is positioned as a durable No. 2 in the obesity drug market, not a loser to Eli Lilly. Click here to read an ...
Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...
Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...
If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...
Hims & Hers Health will be selling some of Novo Nordisk's GLP-1 medications, including Wegovy. Starting Thursday, eligible customers can access Wegovy pills and injections in several different dosage ...
The FDA approves a higher dose of Wegovy (semaglutide) injection for weight loss in adults with obesity or overweight with ...
GLP-1s have quickly become one of the most popular types of weight loss drug in America. Nearly 1 in 5 people have taken them at some point, according to research from KFF, a health information ...
In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results